Literature DB >> 19669333

Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis.

Yohei Kida1, Hiroki Ueda, Hiroto Tanaka, Masakazu Ichinose.   

Abstract

PURPOSE: Evaluation of protein intake of patients with liver cirrhosis (LC) would facilitate optimal nutritional support. However, it has never been done on the basis of urinary urea nitrogen (UUN). The aim of this study, therefore, is to determine the usefulness of the estimated protein intake (EPI) based on UUN in patients with LC.
METHODS: A total of 42 patients with early-stage LC were enrolled in this study. The actual protein intake (API) was defined as the dietary protein intake (1.0 g/kg/d) plus supplementation of any enteral diets containing branched-chain amino acids (BCAA). We calculated EPI from UUN using the formula [UUN (g/d) + 0.031 x body weight (kg)] x 0.625. We examined the correlation between EPI and API, the EPI/API ratio (EAR), and the correction based on the results.
RESULTS: A significant positive correlation was found between API and EPI (r = 0.703, p < 0.001). The EAR in all patients was 0.84 +/- 0.11. EPI times 1.2 was the correction needed to adjust EAR to 1. The corrected EPI was correlated with API (r = 0.704, p < 0.001). The corrected EAR of all 42 patients was 1.01 +/- 0.13.
CONCLUSION: In conclusion, for patients with early-stage LC, an EPI calculated from UUN may be a useful tool for optimal nutritional support. The corrected EPI would be very useful for improved monitoring of early-stage LC.

Entities:  

Year:  2007        PMID: 19669333      PMCID: PMC2716834          DOI: 10.1007/s12072-007-9019-0

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  17 in total

1.  The effect of a late evening snack in patients with liver cirrhosis.

Authors:  Masako Tsuchiya; Isao Sakaida; Mariko Okamoto; Kiwamu Okita
Journal:  Hepatol Res       Date:  2005-01-06       Impact factor: 4.288

2.  Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients.

Authors:  O Selberg; J Böttcher; G Tusch; R Pichlmayr; E Henkel; M J Müller
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

3.  Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Authors:  Yasutoshi Muto; Shunichi Sato; Akiharu Watanabe; Hisataka Moriwaki; Kazuyuki Suzuki; Akinobu Kato; Masahiko Kato; Teiji Nakamura; Kiyohiro Higuchi; Shuhei Nishiguchi; Hiromitsu Kumada
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

4.  Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study).

Authors:  Shunichi Sato; Akiharu Watanabe; Yasutoshi Muto; Kazuyuki Suzuki; Akinobu Kato; Hisataka Moriwaki; Masahiko Kato; Teiji Nakamura
Journal:  Hepatol Res       Date:  2005-03-23       Impact factor: 4.288

5.  Nutrition and survival in patients with liver cirrhosis.

Authors:  F Alberino; A Gatta; P Amodio; C Merkel; L Di Pascoli; G Boffo; L Caregaro
Journal:  Nutrition       Date:  2001-06       Impact factor: 4.008

6.  Administration of granulated BCAA and quality of life.

Authors:  Naohiro Kawamura; Hiroshi Nakajima; Shin-Ichi Takashi
Journal:  Hepatol Res       Date:  2004-12       Impact factor: 4.288

7.  Branched-chain amino acid treatment in patients with liver cirrhosis.

Authors:  Kazuyuki Suzuki; Akinobu Kato; Masakatsu Iwai
Journal:  Hepatol Res       Date:  2004-11-11       Impact factor: 4.288

8.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

9.  Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis.

Authors:  Katsumi Sako; Yasushi Imamura; Hiroto Nishimata; Kenji Tahara; Osamu Kubozono; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2003-08       Impact factor: 4.288

10.  Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis.

Authors:  Mariko Okamoto; Isao Sakaida; Masako Tsuchiya; Chieko Suzuki; Kiwamu Okita
Journal:  Hepatol Res       Date:  2003-09       Impact factor: 4.288

View more
  4 in total

1.  Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria.

Authors:  Birgitta Olsson; Lakshminarayan Ranganath; Jean-Baptiste Arnoux; Richard Imrich; Anna Milan; Mattias Rudebeck
Journal:  JIMD Rep       Date:  2021-11-09

2.  Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria.

Authors:  L R Ranganath; A M Milan; A T Hughes; A S Davison; M Khedr; B P Norman; G Bou-Gharios; J A Gallagher; M Gornall; R Jackson; R Imrich; J Rovensky; M Rudebeck; B Olsson
Journal:  Mol Genet Metab Rep       Date:  2022-02-01

3.  Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.

Authors:  Lakshminarayan R Ranganath; Anna M Milan; Andrew T Hughes; Andrew S Davison; Milad Khedr; Richard Imrich; Mattias Rudebeck; Birgitta Olsson; Brendan P Norman; George Bou-Gharios; James A Gallagher
Journal:  Metabolites       Date:  2022-08-22

4.  Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.

Authors:  L R Ranganath; A M Milan; A T Hughes; A S Davison; Khedr M; B P Norman; G Bou-Gharios; J A Gallagher; R Imrich; J B Arnoux; M Rudebeck; B Olsson
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.